CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 44 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $120,000 | -18.9% | 34,117 | -7.8% | 0.00% | – |
| Q3 2020 | $148,000 | +39.6% | 37,014 | -5.5% | 0.00% | – |
| Q2 2020 | $106,000 | +68.3% | 39,171 | +29.6% | 0.00% | – |
| Q1 2020 | $63,000 | +293.8% | 30,220 | +1914.7% | 0.00% | – |
| Q4 2017 | $16,000 | -84.3% | 1,500 | -76.6% | 0.00% | – |
| Q3 2017 | $102,000 | -8.9% | 6,404 | -31.0% | 0.00% | – |
| Q2 2017 | $112,000 | -24.8% | 9,286 | +29.3% | 0.00% | – |
| Q1 2017 | $149,000 | -62.9% | 7,181 | -72.8% | 0.00% | -100.0% |
| Q4 2016 | $402,000 | – | 26,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
| Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
| BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
| Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
| COWEN INC. | 588,706 | $5,051,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
| EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
| Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
| Hikari Power Ltd | 32,090 | $275,000 | 0.03% |